Canton Hathaway, LLC Guardant Health, Inc. Transaction History
Canton Hathaway, LLC
- $366 Million
- Q2 2024
A detailed history of Canton Hathaway, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Canton Hathaway, LLC holds 2,050 shares of GH stock, worth $47,150. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,050Holding current value
$47,150% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding GH
# of Institutions
330Shares Held
113MCall Options Held
680KPut Options Held
1.66M-
Vanguard Group Inc Valley Forge, PA11.6MShares$268 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$258 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$140 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$104 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$103 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.35B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...